Navigation Links
New Clinical Data Further Supports Chromium Picolinate's Role in Enhancing Brain Activity in Older Adults

Study Used Key Ingredient in Core4Life Advanced Memory Formula(TM)

PURCHASE, N.Y., March 4 /PRNewswire-FirstCall/ -- Nutrition 21, Inc. (Nasdaq: NXXI), a developer and marketer of nutritional supplements that help consumers manage blood sugar levels, improve cardiovascular health, enhance memory and address chronic joint pain, today announced the results of a clinical study that showed daily supplementation with 1000 mcg of chromium, as chromium picolinate, increased brain activity in older adults experiencing early memory decline. Researchers from the University of Cincinnati presented the study results at the 19th annual meeting of the American Neuropsychiatric Association.

Blood circulation and nutrient flow to the brain can decrease with aging and affect cognition. A previous study presented in December 2007 showed that using chromium picolinate, which can improve insulin sensitivity and enhance utilization of glucose -- the brain's main fuel -- improved memory function in older adults.

"The current study showed that older adults taking chromium picolinate exhibited greater brain activation while engaged in a cognitively demanding task," said Robert Krikorian, Ph.D., lead investigator and associate professor, Department of Psychiatry, University of Cincinnati College of Medicine. "These brain imaging results support findings from the prior study suggesting that chromium picolinate may be beneficial for older adults with early memory decline and metabolic irregularities, factors that substantially increase the risk for dementia. These findings substantiate the need for continued research to determine the nature and extent of this enhancement."

The randomized, double-blind, placebo-controlled study measured whether supplementation with chromium picolinate for a 12-week period might affect brain activation under working memory task demands in 13 older adults with early memory decline. Functional magnetic resonance imaging (fMRI) scans were performed while study participants worked on a challenging cognitive task that involved holding in mind and manipulating visual information while resisting potential distractions. Results from the fMRI scans showed that subjects receiving chromium picolinate exhibited greater activation in right thalamic, right temporal, right posterior parietal and bilateral frontal regions (p = .005).

At treatment termination, urinary chromium to creatinine ratios were elevated in the chromium picolinate group (p < .0001). There was no significant difference between the groups with respect to age (72 versus 73 years), education (15.8 versus 17.3 years), mood disturbance (11 versus 4.5 Profile of Mood States score), and level of memory impairment (.89 versus .63 Clinical Dementia Rating sum boxes score).

"The earlier memory study conducted by the University of Cincinnati team in addition to the current data using functional MRI supports the ability of chromium picolinate to help improve working memory in the elderly," said James Komorowski, M.S., Vice President of Scientific Affairs at Nutrition 21. "Since chromium picolinate is one of three core components of our Core4Life Advanced Memory Formula product, we're pleased to see that ongoing research evaluating its effect on cognitive function is showing consistent beneficial results."

Study investigators used Nutrition 21's proprietary chromium picolinate found in Core4Life Advanced Memory Formula(TM), a nutritional supplement specifically formulated to improve brain health. Core4Life Advanced Memory Formula, available in soft gel form, contains chromium picolinate, phosphatidylserine (PS) and DHA. These ingredients have been scientifically tested for their ability to improve cognitive function:
-- Chromium picolinate is an essential trace mineral that promotes healthy

blood sugar levels, which is important because glucose helps fuel the


-- PS is a naturally occurring phospholipid nutrient essential to the

functioning of all cells of the body, but is most concentrated in the

brain. PS supports communication between brain cells and promotes

improved memory.

-- DHA is an omega-3 fatty acid, most commonly found in fish oil, which

maintains brain fluidity and may help in the maintenance of cognitive


Core4Life Advanced Memory Formula is manufactured according to strict Food and Drug Administration (FDA) guidelines. This product can be taken safely alone or with medication, with optimal results seen in 30 to 90 days. Core4Life Advanced Memory Formula is available at major retailers nationwide in the vitamin section. For more information visit

About Nutrition 21

Nutrition 21, Inc. (Nasdaq: NXXI), headquartered in Purchase, NY, is a nutritional bioscience company and the maker of chromium picolinate-based and omega-3 fish oil-based supplements with health benefits substantiated by clinical research. Nutrition 21 holds more than 30 patents for nutrition products and uses. Nutrition 21's portfolio of health and wellness brands include: Chromax(R), Core4Life Advanced Memory Formula(TM), Diabetes Essentials(TM), Iceland Health(R) Maximum Strength Omega-3 and Iceland Health(R) Joint Relief. The company also manufactures private label supplements and ingredients for third parties. Nutrition 21 distributes its products nationally through more than 29,000 major food, drug and super center retailers as well as internationally. For more information please visit

CONTACT: Maryrose Lombardo, 914-701-4525

SOURCE Nutrition 21, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
6. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
7. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
Post Your Comments:
(Date:11/26/2015)... PUNE, India , November 26, ... --> --> ... Research Report" and "Investigation Report on ... 2019 and 2021 forecasts data and ... library. . ...
(Date:11/26/2015)... Nov. 26, 2015 Research and Markets ... the "2016 Future Horizons and Growth Strategies ... Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging ... --> --> This ... the Italian therapeutic drug monitoring market, including emerging ...
(Date:11/26/2015)... , November 26, 2015 ... the addition of the  "2016 Future ... European Cell Surface Marker Testing Market: ...  report to their offering.  --> ... addition of the  "2016 Future Horizons ...
Breaking Medicine Technology:
(Date:11/26/2015)... ... November 26, 2015 , ... Pixel Film ... trailer titles with ProTrailer: Vintage. This newly styled ProTrailer pack comes with 30 ... with any font, giving users limitless opportunities to stylize and create designs quickly ...
(Date:11/25/2015)... ... , ... The holiday season is jam-packed with family dinners, ... attendees is of the utmost importance. Whether you are cooking at home for ... a try this holiday season. , Turkey Croquettes ,     Ingredients: , ...
(Date:11/25/2015)... ... November 26, 2015 , ... Ministers, senior ... (EU), ANDI Pan African Centres of Excellence, and public R&D institutions, civil societies ... the opening of the 5th African Network for Drugs and Diagnostics Innovation, ANDI, ...
(Date:11/25/2015)... ... 2015 , ... Dental professionals who would like to become more proficient on ... Dr. Mark Iacobelli’s Advanced Implant Mentoring (AIM) CE course. Courses will be held on ... co-founders of Advanced Implant Mentoring (AIM), Dr. Iacobelli and Dr. D’Orazio are proud to ...
(Date:11/25/2015)... ... ... Smiles by Stevens is pleased to announce the addition of ... patients are aware of the benefits of Botox® in the treatment of moderate facial ... discomfort, soreness, and pain as a result of Jaw Tension, TMJ (temporo-mandibular joint) disorder, ...
Breaking Medicine News(10 mins):